Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.040 | 14 | 104780190 | missense variant | G/A | snv | 7.0E-06 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 14 | 104770805 | missense variant | T/G | snv |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.770 | 1.000 | 7 | 2008 | 2019 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Musculoskeletal Diseases | 0.730 | 1.000 | 4 | 2008 | 2019 | |||||||
|
1.000 | 0.040 | 14 | 104776711 | missense variant | G/T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
14 | 104792555 | intron variant | C/T | snv | 0.51 | 0.48 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
14 | 104792555 | intron variant | C/T | snv | 0.51 | 0.48 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.080 | 14 | 104776883 | non coding transcript exon variant | G/A | snv | 0.33 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
14 | 104789850 | intron variant | C/T | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 1.000 | 14 | 2008 | 2019 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.060 | 1.000 | 6 | 2013 | 2019 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2008 | 2017 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2007 | 2010 | |||||||
|
0.763 | 0.240 | 14 | 104772855 | intron variant | T/C | snv | 0.50 | 0.47 |
|
Mental Disorders | 0.050 | 0.800 | 5 | 2011 | 2019 | ||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.040 | 1.000 | 4 | 2008 | 2016 | |||||||
|
0.763 | 0.240 | 14 | 104772855 | intron variant | T/C | snv | 0.50 | 0.47 |
|
Chemically-Induced Disorders; Mental Disorders | 0.040 | 0.750 | 4 | 2011 | 2016 | ||||||
|
0.763 | 0.240 | 14 | 104772855 | intron variant | T/C | snv | 0.50 | 0.47 |
|
0.040 | 0.750 | 4 | 2011 | 2019 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2008 | 2015 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2007 | 2008 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2008 | 2017 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2015 | 2018 | |||||||
|
0.595 | 0.640 | 14 | 104780214 | missense variant | C/T | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2008 | 2019 | |||||||
|
0.763 | 0.240 | 14 | 104772855 | intron variant | T/C | snv | 0.50 | 0.47 |
|
Mental Disorders | 0.030 | 0.667 | 3 | 2012 | 2019 | ||||||
|
0.763 | 0.240 | 14 | 104772855 | intron variant | T/C | snv | 0.50 | 0.47 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2006 | 2013 | ||||||
|
0.790 | 0.120 | 14 | 104797271 | upstream gene variant | A/G | snv | 0.85 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2017 | 2018 |